Why Doctor Patient Choice Matters


Dr. David Armstrong, Dr. Paul Moayyedi, Denise and Shayna Ford (mother and daughter), and Mina Mawani (president and CEO of Crohn’s and Colitis Canada) spoke about the impact of non-medical switching and why patient-doctor choice is important. The panel then answered questions from the audience, which included patients, caregivers, healthcare professionals, and members of the community. 

[This video will be made available soon]


As a child, Shayna Ford was diagnosed with inflammatory bowel disease. She and her mom, Denise, shared how they feel about this impending policy change and the importance of leaving treatment decisions in the hands of patients and their healthcare team.



Past President and Current Board Member of the Canadian Association of Gastroenterology Dr. David Armstrong spoke about the impact of non-medical switching policy and why patient-doctor choice is important from the perspective of a gastroenterologist.


  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.

Other Areas of Interest